CardiAMP™ Heart Failure Trial
Purpose
The purpose of this study is to examine if an investigational procedure can correct the parts of the heart muscle that are not working properly due to a previous heart attack. CardiAMP is the first comprehensive therapeutic treatment utilizing a patient's own cells for the treatment of ischemic systolic heart failure, which is heart failure that develops after a heart attack
Procedures
- Approximately 7 study visits over 2 years
- Visits may include bone marrow sampling, physical exam, electrocardiogram
Eligibility
- 21-90 years old
- Heart failure
Age
Gender
Monetary compensation
Can be done from home
Keywords
Heart failure - overview, Heart Failure, Cardiomyopathy, bone marrow, Ischemic cardiomyopathyPrincipal Investigator
Carl Pepine, MDDepartment
Contact Information
Janette.Bostick@medicine.ufl.edu
Begin a new search for other research studies
Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.